Wealthfront Advisers’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956K | Buy |
|
|||||
|
2025
Q1 | $815K | Sell |
|
|||||
|
2024
Q4 | $1.01M | Sell |
|
|||||
|
2024
Q3 | $1.29M | Sell |
|
|||||
|
2024
Q2 | $1.22M | Sell |
|
|||||
|
2024
Q1 | $1.29M | Buy |
|
|||||
|
2023
Q4 | $901K | Buy |
|
|||||
|
2023
Q3 | $676K | Buy |
|
|||||
|
2023
Q2 | $626K | Sell |
|
|||||
|
2023
Q1 | $646K | Buy |
|
|||||
|
2022
Q4 | $674K | Sell |
|
|||||
|
2022
Q3 | $648K | Buy |
|
|||||
|
2022
Q2 | $552K | Buy |
|
|||||
|
2022
Q1 | $454K | Buy |
|
|||||
|
2021
Q4 | $295K | Buy |
|